BioNTech SE
BNTX
$93.66
$0.320.34%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -610.40M | -355.05M | -33.55M | -438.76M | -437.57M |
| Total Depreciation and Amortization | 139.20M | -38.07M | 145.20M | 57.88M | 45.04M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -87.91M | 1.02B | 48.17M | -62.31M | 20.42M |
| Change in Net Operating Assets | 75.97M | -264.72M | 752.91M | 609.46M | -449.46M |
| Cash from Operations | -483.13M | 360.29M | 912.73M | 166.27M | -821.57M |
| Capital Expenditure | -65.18M | -73.57M | -41.97M | -30.76M | -51.46M |
| Sale of Property, Plant, and Equipment | 1.84M | 698.50K | 3.39M | 567.50K | 526.20K |
| Cash Acquisitions | -- | 308.25M | -- | -- | -82.61M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 3.11B | -3.41B | -1.04B | -42.90M | 1.45B |
| Cash from Investing | 3.04B | -3.17B | -1.08B | -73.09M | 1.31B |
| Total Debt Issued | 38.40M | 6.70M | -- | -- | -- |
| Total Debt Repaid | -12.00M | -19.00M | -11.50M | -13.30M | -13.80M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -2.00M | -- | -- | -- |
| Cash from Financing | 30.30M | -16.65M | -13.44M | -15.09M | -14.52M |
| Foreign Exchange rate Adjustments | -3.90M | 1.63M | -25.14M | 10.44M | -16.94M |
| Miscellaneous Cash Flow Adjustments | 13.08M | 13.39M | 1.17M | 7.49M | -13.89M |
| Net Change in Cash | 2.60B | -2.81B | -206.47M | 96.02M | 445.14M |